Sowell Financial Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,580
Closed -$328K 1195
2021
Q1
$328K Sell
3,580
-321
-8% -$27.1K 0.01% 807
2020
Q4
$356K Sell
3,901
-98
-2% -$8.13K 0.02% 631
2020
Q3
$319K Buy
3,999
+948
+31% +$74K 0.02% 596
2020
Q2
$211K Sell
3,051
-2,367
-44% -$168K 0.01% 703
2020
Q1
$341K Sell
5,418
-264
-5% -$19K 0.03% 504
2019
Q4
$442K Buy
5,682
+3,675
+183% +$287K 0.03% 484
2019
Q3
$147K Buy
+2,007
New +$141K 0.01% 729

Other funds holding EW

Sowell Financial Services's EW Position: Q2 2021 in Review

Sowell Financial Services sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 3,580 shares — an estimated $328K sold.

Sowell Financial Services first reported a position in EW in Q3 2019 and held it in 7 quarters. The position peaked at $442K in Q4 2019. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • Sowell Financial Services reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 3,580 Edwards Lifesciences shares in Q2 2021, an estimated $328K.
  • Sowell Financial Services first reported a position in Edwards Lifesciences in Q3 2019 and held it in 7 quarters.
  • Sowell Financial Services's Edwards Lifesciences position peaked at $442K in Q4 2019.
  • 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.